Literature DB >> 23290706

Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study.

Mehmet Polatli1, Ali Ben Kheder, Siraj Wali, Arshad Javed, Adel Khattab, Bassam Mahboub, Ghali Iraqi, Chakib Nejjari, Samya Taright, Marie-Louise Koniski, Nauman Rashid, Abdelkader El Hasnaoui.   

Abstract

Data on COPD-related healthcare resources use are rarely documented in developing countries. This article presents data on COPD-related healthcare resource consumption in the Middle East, North Africa and Pakistan and addresses the association of this variable with illness severity. A large survey of COPD was conducted in eleven countries of the region, namely Algeria, Egypt, Jordan, Lebanon, Morocco, Pakistan, Saudi-Arabia, Syria, Tunisia, Turkey and United Arab Emirates, using a standardised methodology. A total of 62,086 subjects were screened. This identified 2,187 subjects fulfilling the "epidemiological" definition of COPD. A detailed questionnaire was administered to document data on COPD-related healthcare consumption. Symptom severity was assessed using the COPD Assessment Test (CAT). 1,392 subjects were analysable. Physician consultations were the most frequently used healthcare resource, ranging from 43,118 [95% CI: 755-85,548] consultations in UAE to 4,276,800 [95% CI: 2,320,164-6,230,763] in Pakistan, followed by emergency room visits, ranging from 15,917 [95% CI: 0-34,807] visits in UAE to 683,697 [95% CI: 496,993-869,737] in Turkey and hospitalisations, ranging from 15,563 [95% CI: 7,911-23,215] in UAE to 476,674 [95% CI: 301,258-652,090] in Turkey. The use of each resource increased proportionally with the GOLD 2011 severity groups and was significantly (p < 0.0001) higher in subjects with more symptoms compared to those with lower symptoms and in subjects with exacerbations to those without exacerbations. The occurrence of exacerbations and the CAT score were independently associated with use of each healthcare resource. In conclusion, the BREATHE study revealed that physician consultation is the most frequently COPD-related healthcare resource used in the region. It showed that the deterioration of COPD symptoms and the frequency of exacerbations raised healthcare resource consumption.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23290706     DOI: 10.1016/S0954-6111(12)70016-1

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  21 in total

Review 1.  Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.

Authors:  Kunal Srivastava; Deepika Thakur; Sheetal Sharma; Yogesh Suresh Punekar
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

2.  Serious fungal infections in Egypt.

Authors:  S M Zaki; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-17       Impact factor: 3.267

3.  Burden of fungal infections in Algeria.

Authors:  M Chekiri-Talbi; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-21       Impact factor: 3.267

4.  Chronic Obstructive Pulmonary Disease and Associated Factors in Arba Minch Health and Demographic Surveillance Site, 2020.

Authors:  Eskezyiaw Agedew; Belay Boda; Tesfaye Kanko; Wubshet Estifanos; Tamiru Shibiru
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-28

5.  Five-Year Trends in Direct Costs of Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-3.

Authors:  Tarkan Ozdemir; Hatice Kilic; Nilgun Yilmaz Demirci; Cigdem Ozdilekcan; Guven Bektemur; Mustafa Hamidullah Turkkani; Simten Malhan; H Canan Hasanoglu; Orhan Koc; Can Ozturk
Journal:  Turk Thorac J       Date:  2021-09

6.  The Saudi guidelines for chronic obstructive pulmonary disease: A fresh "Real-World" approach to COPD.

Authors:  Nicola A Hanania
Journal:  Ann Thorac Med       Date:  2014-04       Impact factor: 2.219

7.  Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, Russia.

Authors:  Ivan P Artyukhov; Irina L Arshukova; Elena A Dobretsova; Tatyana A Dugina; Andrey V Shulmin; Irina V Demko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-02

8.  Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.

Authors:  Sarah H Landis; Hana Muellerova; David M Mannino; Ana M Menezes; MeiLan K Han; Thys van der Molen; Masakazu Ichinose; Zaurbek Aisanov; Yeon-Mok Oh; Kourtney J Davis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-06

9.  Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.

Authors:  Jason Foo; Sarah H Landis; Joe Maskell; Yeon-Mok Oh; Thys van der Molen; MeiLan K Han; David M Mannino; Masakazu Ichinose; Yogesh Punekar
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

10.  Current care services provided for patients with COPD in the Eastern province in Saudi Arabia: a descriptive study.

Authors:  Mohammed E Alsubaiei; Paul A Cafarella; Peter A Frith; R Doug McEvoy; Tanja W Effing
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.